LILLY ASIA VENTURES
Lilly Asian Ventures makes venture capital investments in Asia for Eli Lilly and Company, a global innovation-driven pharmaceutical company. Lilly Asian Ventures invests in promising life science companies with strong management teams and innovative technology and/or business models. Their initial focus will be primarily on opportunities in China, although they will consider investment opportunities elsewhere in east and south Asia.
LILLY ASIA VENTURES
Industry:
Biotechnology Pharmaceutical Venture Capital
Founded:
2008-01-01
Status:
Active
Contact:
+86 21 2316 9588
Technology used in webpage:
SSL By Default ASP.NET IIS DigiCert SSL ASP.NET 4.0 IIS 8 Encryption Everywhere China Telecom
Similar Organizations
ARCH Venture Partners
ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
Wisconsin Investment Partners
Wisconsin Investment Partners is an Angel Investment Group in Madison, Wisconsin founded in 2000 with 20 members.
Current Advisors List
Board_member
Current Employees Featured
Yi Shi Managing Director & Founder @ Lilly Asia Ventures
Managing Director & Founder
2008-01-01
Judith Li Partner @ Lilly Asia Ventures
Partner
2013-01-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-02 | Neukio Biotherapeutics | Lilly Asia Ventures investment in Series A - Neukio Biotherapeutics | 50 M USD |
| 2022-07-04 | ClinChoice昆翎 | Lilly Asia Ventures investment in Series E - ClinChoice昆翎 | 150 M USD |
| 2022-06-02 | ProfoundBio | Lilly Asia Ventures investment in Series A - ProfoundBio | 70 M USD |
| 2022-04-07 | Rona Therapeutics | Lilly Asia Ventures investment in Series A - Rona Therapeutics | 33 M USD |
| 2022-03-14 | IMPACT Therapeutics | Lilly Asia Ventures investment in Series D - IMPACT Therapeutics | N/A |
| 2022-02-28 | GluBio Therapeutics | Lilly Asia Ventures investment in Series A - GluBio Therapeutics | 50 M USD |
| 2022-02-15 | ArriVent Biopharma | Lilly Asia Ventures investment in Series A - ArriVent Biopharma | 69 M USD |
| 2022-02-08 | Pilot Biotechnology | Lilly Asia Ventures investment in Series C - Pilot Biotechnology | 100 M CNY |
| 2022-01-06 | Virtue Diagnostics | Lilly Asia Ventures investment in Series B - Virtue Diagnostics | 100 M USD |
| 2022-01-01 | ImmuneOnco Biopharma | Lilly Asia Ventures investment in Series C - ImmuneOnco Biopharma | 100 M USD |
More informations about "Lilly Asia Ventures"
Lilly Asia Ventures - Crunchbase Investor Profile
Lilly Asian Ventures makes venture capital investments in Asia for Eli Lilly and Company, a global innovation-driven pharmaceutical company. Lilly Asian Ventures invests in promising life science companies with strong management …See details»
Lilly Asia Ventures - The Org
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm, with offices in Shanghai, Hong Kong, and Palo Alto. Originated in 2008 as a corporate venture subsidiary of Eli Lilly, they spun off and became an independent …See details»
Lilly Asia Ventures investment portfolio | PitchBook
May 30, 2024 Founded in 2008, Lilly Asia Ventures is a corporate venture capital arm of Eli Lilly headquartered in Hongkong. The firm prefers to invest in seed-stage, early-stage, and later …See details»
Lilly Asia Ventures 礼来亚洲基金 - LinkedIn
Lilly Asia Ventures 礼来亚洲基金 | 1,700 followers on LinkedIn. Lilly Asia VenturesSee details»
Lilly Asia Ventures - Investments, Portfolio & Company Exits
Lilly Asian Ventures is an investment firm that invests in promising life science companies. New. ... Lilly Asia Ventures has made 19 diversity investments. Their most recent diversity …See details»
Lilly Asia Ventures - Private Equity International
Lilly Asia Ventures. News, insights, analysis and data. Lilly Asia Ventures overview. Founded in 2008, Lilly Asia Ventures is a biomedical venture capital firm that focuses on investments …See details»
Lilly Asia Ventures - CB Insights
About Lilly Asia Ventures. Lilly Asia Ventures (LAV) is a biomedical venture capital firm, with offices in Shanghai, Hong Kong, and Palo Alto. Its vision is to become the trusted partner for …See details»
Lilly Asia Ventures Portfolio Companies - Crunchbase
Lilly Asian Ventures is an investment firm that invests in promising life science companies. This list of organizations invested in by Lilly Asia Ventures provides data on their funding history, …See details»
Lilly Asia Ventures - Company Profile and News - Bloomberg …
Lilly Asia Ventures operates as a venture capital company. The Company invests in biological science, medical device, diagnostic, and health care fields. Lilly Asia Ventures serves …See details»
Lilly Asia Ventures - e27 Investor Profile
Lilly Asian Ventures makes venture capital investments in Asia for Eli Lilly and Company, a global innovation-driven pharmaceutical company. Verify Your Email Address. Your account contact email hasn't been verified yet. Please verify …See details»
Lilly Asia Ventures company information, funding & investors
Lilly Asia Ventures, makes venture capital investments in asia for eli lilly and company, a global innovation-driven pharmaceutical. Here you'll find information about their funding, investors …See details»
Lilly Asia Ventures Investor Profile: Investments, Portfolio & Exits
Investors > Lilly Asia Ventures. Lilly Asia Ventures Lilly Asia Ventures, founded in 2008 and headquartered in Shanghai, is a life sciences and healthcare sector focused venture capital …See details»
Lilly Asia Ventures | Investors | Mindmaps
Lilly Asian Ventures invests in promising life science companies with strong management teams and innovative technology and/or business models. Their initial focus will be primarily on …See details»
Lilly Asia Ventures – Investors Database - Unicorn Nest
Opposing the other organizations, this Lilly Asia Ventures works on 15 percentage points less the average amount of lead investments. The increased amount of exits for fund were in 2019. …See details»
Lilly Asia Ventures - vcinvestorlist.com
Lilly Asian Ventures is an investment firm that invests in promising life science companies. Number of Investments: 207 Number of Exits: 45 Investment Industries: …See details»
Lilly Asia Ventures - Funding, Financials, Valuation & Investors
Lilly Asia Ventures has raised 2 funds, their latest being LAV Biosciences Fund V. This fund was announced on Feb 14, 2019 and raised a total of . obfuscated. obfuscated. Announced Date . …See details»
Lilly Asia Ventures Reaches USD1.35b Final Close for Health Care …
Feb 3, 2021 An independent, non-profit organization, the association brings together 300+ firms—including institutional investors, fund managers, and industry advisors—who manage …See details»
Li Qin · Lilly Asia Ventures · Suite 2909, 3 Corporate ... - OpenGovNY
LI QIN (Registration #4938007) is an attorney in Shanghai admitted in New York State in 2011, registered with the Office of Court Administration (OCA) of New York State Unified Court …See details»
Lilly Asia Ventures - Contacts, Employees, Board Members
Lilly Asia Ventures has 3 current employee profiles, including Managing Director & Founder Yi Shi. Lilly Asia Ventures has 1 board member or advisor, Li Kaixin. Contacts. Edit Contacts …See details»
In Conversation: Sketching The Future Of Biotech Investment With …
Mar 24, 2025 Laura Lane, European head of Lilly Ventures, talked to In Vivo at the recent Bio-Europe meeting in a fireside chat about how strategic investments are shaping the future of …See details»